Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial
Nutrients · 29.06.2025 · 17 (13) · 2164
DOI: 10.3390/nu17132164 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 29.06.2025. Verfasst von Gopal Lamichhane und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA. Hauptthemen laut MEDLINE: Curcumin, Prediabetic State, Blood Glucose, Homeostasis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oklahoma State University, Ottogi Ham Taiho Foundation, OTTOGI HAM TAIHO Foundation and Barbara K. Pass Nutritional Sciences Research Grant in the Department of Nutritional Sciences at Oklahoma State University.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
The prevalence of diabetes increases with age, and food bioactive compounds have shown potential in mitigating its development. This study aimed to evaluate the efficacy of curcumin in preventing type 2 diabetes mellitus (T2DM) in older adults with prediabetes. We hypothesized that curcumin, due to its insulin-sensitizing effects, would help maintain glucose homeostasis, metabolic health, and gut health.
Methods
This randomized, double-blind, placebo-controlled trial included 28 older adults (aged 60 years or older) with prediabetes or overweight/obesity. Participants were randomly assigned to receive either curcumin (80 mg) or placebo capsules for 12 weeks. The primary outcome measures were glucose homeostasis markers, including hemoglobin A1c (HbA1c), blood glucose, and insulin levels. Secondary outcomes included body composition, body mass index (BMI), body weight, lipid profiles, and gut microbiome composition. Data normality was assessed using the Shapiro–Wilk test, and two-way repeated-measures ANOVA with multiple comparisons was used to find differences between groups and over time.
Results
A total of 23 participants (age = 66.52 ± 5.76 years; 14 in the curcumin group and 9 in the placebo group) completed the 12-week intervention. HbA1c levels significantly decreased in the curcumin group, whereas levels remained stable in the placebo group. While the curcumin group observed an increase in AST levels, the ALT level was reduced in the placebo group. Both the curcumin and placebo groups showed a reduced ALT/AST ratio by the end of the intervention. Body mass index, lipid profiles, and body composition showed no significant changes over the study period. Gut microbiome analysis revealed no significant changes in alpha diversity or beta diversity of microbiome; however, there was marginal enrichment of beneficial bacteria such as Bacteroidota (phylum), Bacteroidaceae (family), Agathobacter, Bacteroides, and Roseburia (genera) in the curcumin-supplemented group over time.
Conclusions
Curcumin supplementation improved or favorably maintained glucose homeostasis and showed modest improvements in beneficial gut microbiota in older adults with prediabetes, potentially reducing the risk of developing diabetes. Long-term studies with larger sample sizes are needed to confirm these findings and determine the clinical relevance of curcumin supplementation for prediabetes prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA.
- Department of Animal and Food Sciences, Oklahoma State University, Stillwater, OK 74078, USA.
ORCID-Profile: Gopal Lamichhane, Tyler J Godsey, Jing Liu, Guolong Zhang, Sam R Emerson, Yoo Kim
Förderung
- Oklahoma State University
- Ottogi Ham Taiho Foundation
- OTTOGI HAM TAIHO Foundation and Barbara K. Pass Nutritional Sciences Research Grant in the Department of Nutritional Sciences at Oklahoma State University
Zitieren
APA
Lamichhane, G., Godsey, T. J., Liu, J., Franks, R., Zhang, G., Emerson, S. R., & Kim, Y. (2025). Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial. Nutrients, 17(13), 2164. https://doi.org/10.3390/nu17132164
Vancouver
Lamichhane G, Godsey TJ, Liu J, Franks R, Zhang G, Emerson SR, et al. Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial. Nutrients. 2025;17(13):2164. doi:10.3390/nu17132164
BibTeX
@article{Lamichhane2025,
author = {Lamichhane, Gopal and Godsey, Tyler J and Liu, Jing and Franks, Rienna and Zhang, Guolong and Emerson, Sam R and Kim, Yoo},
title = {Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {13},
pages = {2164},
doi = {10.3390/nu17132164}
}
EUVIMED